AMR Awareness Week: Way forward for pharma companies to ensure antibiotics manufacturing doesn’t drive resistance
The risk of AMR posed by the release of antibiotic manufacturing waste can be prevented
Pharma is getting high on marijuana
As drug companies develop cannabis-based medicines for serious illnesses, generic firms are trying to get into the act
US is finally trying to rein in drug giants
Biden government’s push to get Big Pharma to reduce the astronomical rates of prescription medicines is significant
More give than take in secret trade deals
The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly